药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Podofilox
PEV3A
The therapeutic efficacy of PEV3A can be decreased when used in combination with Pazopanib.
Podofilox
G17DT
The therapeutic efficacy of G17DT can be decreased when used in combination with Pazopanib.
Podofilox
Osimertinib
The serum concentration of Pazopanib can be decreased when it is combined with Osimertinib.
Podofilox
Methotrimeprazine
The metabolism of Pazopanib can be decreased when combined with Methotrimeprazine.
Podofilox
Lorcaserin
The metabolism of Lorcaserin can be decreased when combined with Pazopanib.
Podofilox
Rhein
The metabolism of Pazopanib can be decreased when combined with Rhein.
Podofilox
Dosulepin
The metabolism of Dosulepin can be decreased when combined with Pazopanib.
Podofilox
Ritanserin
The metabolism of Pazopanib can be decreased when combined with Ritanserin.
Podofilox
Manidipine
The metabolism of Pazopanib can be decreased when combined with Manidipine.
Podofilox
Phenylbutyric acid
The metabolism of Pazopanib can be decreased when combined with Phenylbutyric acid.
Podofilox
Vilazodone
The metabolism of Pazopanib can be decreased when combined with Vilazodone.
Podofilox
Sulfaphenazole
The metabolism of Pazopanib can be decreased when combined with Sulfaphenazole.
Podofilox
Lumefantrine
The metabolism of Lumefantrine can be decreased when combined with Pazopanib.
Podofilox
Panobinostat
The metabolism of Panobinostat can be decreased when combined with Pazopanib.
Podofilox
Pazufloxacin
The metabolism of Pazopanib can be decreased when combined with Pazufloxacin.
Podofilox
Relugolix
The risk or severity of QTc prolongation can be increased when Relugolix is combined with Pazopanib.
Podofilox
Fostemsavir
The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Pazopanib.
Podofilox
Lurasidone
The risk or severity of QTc prolongation can be increased when Lurasidone is combined with Pazopanib.
Podofilox
Gallopamil
The risk or severity of QTc prolongation can be increased when Gallopamil is combined with Pazopanib.
Podofilox
Inotersen
The risk or severity of QTc prolongation can be increased when Inotersen is combined with Pazopanib.